Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor - PubMed (original) (raw)

. 2008 Feb:31 Suppl 2:S125-30.

doi: 10.2337/dc08-s231.

Affiliations

• PMID: 18227472
• DOI: 10.2337/dc08-s231

Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor

Matthew C Riddle. Diabetes Care. 2008 Feb.

No abstract available

PubMed Disclaimer

Similar articles

• Early insulin use in type 2 diabetes: what are the cons?
  Chiasson JL. Chiasson JL. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S270-4. doi: 10.2337/dc09-S321. Diabetes Care. 2009. PMID: 19875563 Free PMC article. Review. No abstract available.
• Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
  Vos RC, Rutten GEHM. Vos RC, et al. JAMA. 2017 Oct 17;318(15):1489-1490. doi: 10.1001/jama.2017.13463. JAMA. 2017. PMID: 29049639
• Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
  Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA). Gross JL, et al. Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Ann Intern Med. 2011. PMID: 21576535 Review.

Cited by

• Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
  Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. BMJ Open Diabetes Res Care. 2022. PMID: 35504696 Free PMC article.
• Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density.
  Chen K, Wu R, Mo B, Yan X, Shen D, Chen M. Chen K, et al. J Musculoskelet Neuronal Interact. 2021 Mar 1;21(1):142-148. J Musculoskelet Neuronal Interact. 2021. PMID: 33657765 Free PMC article.
• Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.
  Lynam A, McDonald T, Hill A, Dennis J, Oram R, Pearson E, Weedon M, Hattersley A, Owen K, Shields B, Jones A. Lynam A, et al. BMJ Open. 2019 Sep 26;9(9):e031586. doi: 10.1136/bmjopen-2019-031586. BMJ Open. 2019. PMID: 31558459 Free PMC article.
• Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.
  Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, DiGenio A. Blonde L, et al. Diabetes Spectr. 2019 May;32(2):93-103. doi: 10.2337/ds17-0082. Diabetes Spectr. 2019. PMID: 31168279 Free PMC article.
• A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy.
  Suzuki T, Takahashi K, Fujiwara D, Shii M, Takekawa S, Matsuoka T. Suzuki T, et al. Diabetol Int. 2015 Oct 6;7(3):235-243. doi: 10.1007/s13340-015-0239-6. eCollection 2016 Sep. Diabetol Int. 2015. PMID: 30603269 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information